Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.029 | 0.8 |